Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,793 public trials 2,176 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

NCT05584657

Conditions
Cystitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • Medical Facility Cullman, Alabama, United States
  • Medical Facility Saraland, Alabama, United States
  • Medical Facility Sheffield, Alabama, United States
  • Medical Facility Peoria, Arizona, United States
View all 167 locations
View Trial Details
Completed

Study of Continuous OSI-906 Dosing

NCT00514007

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
Locations
  • Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View Trial Details
Completed

Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis

NCT05324878

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations
  • DaVita World Headquarters Denver, Colorado, United States
  • American Renal Associates LLC Corporate Office Beverly, Massachusetts, United States
  • Fresenius Medical Care Corporate Headquarters Waltham, Massachusetts, United States
View Trial Details
Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 308 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00662909

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Montgomery, Alabama, United States
View all 125 locations
View Trial Details
Completed

Study of Intermittent OSI-906 Dosing

NCT00514306

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Drug Development Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom
View Trial Details

Related conditions